Skip to content

Strategies to optimize antiretroviral therapy services for maternal & child health: the MCH-ART study

Strategies to optimize antiretroviral therapy services for maternal & child health: the MCH-ART study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201411000884278
Enrollment
1600
Registered
2014-09-11
Start date
2013-04-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Sponsors

Columbia University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Phase 1 Age 18 years or older Documented HIV-infection according to two finger-prick rapid tests using different test types (per routine protocol in this setting) or documentation of HIV status for those women self reporting HIV diagnosis. Confirmed pregnancy according to urine pregnancy test, ultrasound or clinical assessment Has not initiated triple-drug antiretroviral therapy or AZT for PMTCT during the current pregnancy Able to provide informed consent for research (Informed Consent #1) Phase 2: Subset of Phase 1 participants who are ART-eligible Consented and participated in Phase 1 Documented ART eligibility based on current local guidelines Started or scheduled to start ART at Gugulethu MOU in the current pregnancy (women started on AZT for PMTCT during the current pregnancy are eligible) Women who were previously receiving lifelong ART must have not used ART for at least 6 months. Able to provide informed consent for research (Informed Consent #2) Phase 3: Subset of Phase 2 participants eligible for randomization Consented and participated in Phase 2 Initiated ART during the antenatal period Currently breastfeeding within <7 days postpartum (with an allowable window of up to 28 days postpartum) Willingness to be randomized and return for postnatal study visits Able to provide informed consent for research (Informed Consent #3)

Exclusion criteria

Exclusion criteria: Not currently pregnant (Phases 1 and 2) or loss of pregnancy/neonate (Phase 3) at the time of eligibility determination Intention to relocate out of Cape Town permanently during the study period (Phase 2 and 3 only) Any medical, psychiatric or social condition which in the opinion of the investigators would affect the ability to consent and/or participate in the study (all phases), including: o Refusal to take ART/ARVs o Denial of HIV status

Design outcomes

Primary

MeasureTime frame
To compare an MCH-focused ART service to general adult ART services as strategies for providing ART during the postpartum period on (i) maternal HIV viral suppression, and (ii) maternal retention in ART services, at 12 months postpartum.

Secondary

MeasureTime frame
To characterize the health status of the population of HIV+ pregnant women seeking antenatal care at the Gugulethu Midwife Obstetric Unit (MOU) including maternal and infant outcomes ;To describe uptake and timing of services received throughout the PMTCT cascade, including antenatal ART initiation and follow-up, at the Gugulethu MOU;To describe changes in women¿s clinical and/or psychosocial characteristics between the antenatal and postnatal periods, and investigate how these are independently associated with the primary outcome;To compare MCH-focused ART services to general adult ART services on:

Countries

South Africa

Contacts

Public ContactTammy Phillips

Project Coordinator

tamsinkatephillips@gmail.com+27216506713

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026